AFP
TNDM icon

Ausdal Financial Partners’s Tandem Diabetes Care TNDM Stock Holding History

Ausdal Financial Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,000
Closed -$2K – 290
2018
Q4 		$2K Hold
11,000
– – ﹤0.01% 249
2018
Q3 		$63K Buy
+11,000
New +$384K 0.02% 409

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ausdal Financial Partners's TNDM Position: Q1 2023 in Review

Ausdal Financial Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 6,479 shares — an estimated $291K sold.

Ausdal Financial Partners first reported a position in TNDM in Q4 2017 and held it in 21 quarters. The position peaked at $897K in Q3 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Ausdal Financial Partners reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Ausdal Financial Partners sold 6,479 Tandem Diabetes Care shares in Q1 2023, an estimated $291K.
  • Ausdal Financial Partners first reported a position in Tandem Diabetes Care in Q4 2017 and held it in 21 quarters.
  • Ausdal Financial Partners's Tandem Diabetes Care position peaked at $897K in Q3 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Ausdal Financial Partners's 13F filing for Q1 2023, filed 4 May 2023.